Non-small cell lung cancer patients with mutations in p53 and patients with alterations in p53 and/or Sp1 showed hypermethylated promoter regions of tumor-suppressor genes (p=0.003–0.016), most likely due to DNMT1 overexpression (42). This evidence concerns the gene TP53 and neoplasm.